The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking ...

Tattoos have become a form of self-expression. Unfortunately, observers mostly misread these inky cues and misjudge the ...

Recent developments that have caused concern include removing all members of a scientific committee that advises the Centers for Disease Control and Prevention (CDC) on vaccines and replacing them ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

The S&P 500 added 0.5% on Wednesday, July 2, 2025, reaching a record-high close for the second time this week as the U.S.

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...